Skip to content

proGAV 2.0® FX478TRecalls & reported problems

Christoph Miethke GmbH & Co. KG · PROGAV 2.0 WITH SA20 A.CONTROL RESERVOIR · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04041906137113), received between Dec 13, 2021 and Dec 13, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Mechanical Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Mechanical Problem1

Patient problems

  • Hydrocephalus1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 13, 2021Mechanical Problem; Mechanical Problem

    ACCORDING TO THE COMPLAINANT A PROGAV WAS "HAD A DEFECT" POSTOPERATIVELY. THE VALVE WAS IMPLANTED IN (B)(6) 2017. IT WAS REMOVED ON (B)(6) 2017 DUE TO THE MALFUNCTION AND RETURNED TO THE MANUFACTURER. FURTHER DETAILS WERE NOT PROVIDED. HEIGHT: 170 CM.

    Patient problems: Hydrocephalus

    MAUDE report 12984478 ↗

Other Shunt, central nervous system and components devices

All Shunt, central nervous system and components devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page